ReviewCurrent hematologic malignancy reports2022
MRD in ALL: Optimization and Innovations.
Eric Pierce et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it
ReviewCurrent hematologic malignancy reports2022
Eric Pierce et al.PubMed ↗Publisher ↗
No numbers read from the abstract.